Understanding Heterogeneity in Patients’ Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster Analysis
Hsiao B, Downs J, Lanyon M, Blalock S, Curtis J, Harrold L, Nowell W, Wiedmeyer C, Venkatachalam S, Patterson M, Gavigan K, Stradford L, Ali D, Fraenkel L. Understanding Heterogeneity in Patients’ Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster Analysis. BMJ Open 2023, 13: e070848. PMID: 37666546, PMCID: PMC10481841, DOI: 10.1136/bmjopen-2022-070848.Peer-Reviewed Original ResearchMeSH KeywordsAntirheumatic AgentsArthritis, RheumatoidCluster AnalysisConcept FormationHumansMental ProcessesConceptsDisease-modifying antirheumatic drugsMedication adherencePatients' conceptualisationRA treatmentRisk/benefit ratioEffective patient-physician communicationFull medication adherenceRheumatoid arthritis managementPatient-physician communicationLower decisional conflictHigh-quality careOnly significant demographic predictorPatient hesitancyAntirheumatic drugsDisease activityPhysician recommendationArthritis managementRheumatoid arthritisSignificant demographic predictorsEligible participantsPatient interviewsResearch RegistryTreatment variesDecisional conflictQuality care